Needle-Trap labels by Schreiner MediPharm now used in China

Schreiner MediPharm, a Germany-based global provider of labels for the healthcare industry, has equipped prefilled enoxaparin-sodium syringes from Kingfriend China, a provider of heparin and heparin products, with its Needle-Trap technology.

Kingfriend is the first Chinese pharmaceutical company to use Schreiner MediPharm’s Needle-Trap for prefilled syringes.

The move marks the first application of a China-based product for Schreiner MediPharm’s needlestick prevention system. Needle-Trap has safeguarded more than 1.2 billion syringes in many international markets since its introduction in 2009.

Kingfriend offers its anticoagulant medication for thrombosis prevention as an enoxaparin-sodium solution in prefilled syringes. For its European market launch, the company was looking for a cost-efficient needle protection solution that meets all legal requirements.  

The needle protection label with an integrated trap marks the syringe and helps protect healthcare staff against needlestick injuries. Needle-Trap meets requirements of EU Directive 2010/32/EU for protection against injuries, as wel as DIN EN ISO 23908 for protection against sharps.

The trap component is directly connected to the label, and features a particularly compact construction. As a result, the heparin syringes’ secondary packaging does not need to be modified, saving both warehousing and logistics costs. In addition, the economical solution requires only minimal production process adaptations.

The prefilled enoxaparin-sodium syringe with Needle-Trap was launched in Germany in the fall of 2020; the product is marketed via partner company Venipharm.

 

Related content